ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Differential Inhibition of Aminopeptidase A and Aminopeptidase N by New .beta.-Amino Thiols

Cite this: J. Med. Chem. 1994, 37, 18, 2950–2957
Publication Date (Print):September 1, 1994
    ACS Legacy Archive

    Article Views





    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 89 publications.

    1. Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents. Journal of Medicinal Chemistry 2018, 61 (15) , 6468-6490.
    2. Anke Hahnenkamp, Michael Schäfers, Christoph Bremer, and Carsten Höltke . Design and Synthesis of Small-Molecule Fluorescent Photoprobes Targeted to Aminopeptdase N (APN/CD13) for Optical Imaging of Angiogenesis. Bioconjugate Chemistry 2013, 24 (6) , 1027-1038.
    3. Geetha Velmourougane, Michael B. Harbut, Seema Dalal, Sheena McGowan, Christine A. Oellig, Nataline Meinhardt, James C. Whisstock, Michael Klemba, and Doron C. Greenbaum . Synthesis of New (−)-Bestatin-Based Inhibitor Libraries Reveals a Novel Binding Mode in the S1 Pocket of the Essential Malaria M1 Metalloaminopeptidase. Journal of Medicinal Chemistry 2011, 54 (6) , 1655-1666.
    4. Christine Anne,, Serge Turcaud,, Jean Quancard,, Franck Teffo,, Hervé Meudal,, Marie-Claude Fournié-Zaluski, and, Bernard P. Roques. Development of Potent Inhibitors of Botulinum Neurotoxin Type B. Journal of Medicinal Chemistry 2003, 46 (22) , 4648-4656.
    5. Christelle David,, Laurent Bischoff,, Hervé Meudal,, Aurélie Mothé,, Nadia De Mota,, Sophie DaNascimento,, Catherine Llorens-Cortes,, Marie-Claude Fournié-Zaluski, and, Bernard P. Roques. Investigation of Subsite Preferences in Aminopeptidase A (EC Led to the Design of the First Highly Potent and Selective Inhibitors of This Enzyme. Journal of Medicinal Chemistry 1999, 42 (25) , 5197-5211.
    6. Loïc Martin,, Fabrice Cornille,, Pascale Coric,, Bernard P. Roques, and, Marie-Claude Fournié-Zaluski. β-Amino-thiols Inhibit the Zinc Metallopeptidase Activity of Tetanus Toxin Light Chain. Journal of Medicinal Chemistry 1998, 41 (18) , 3450-3460.
    7. Laurent Bischoff,, Christelle David,, Loïc Martin,, Hervé Meudal,, Bernard-Pierre Roques, and, Marie-Claude Fournié-Zaluski. 2,4-Dinitrophenyl 4-Methoxybenzyl Disulfide:  A New Efficient Reagent for the Electrophilic Sulfenylation of β-Amino Ester Enolates. The Journal of Organic Chemistry 1997, 62 (14) , 4848-4850.
    8. Arlinda Bytyqi-Damoni, Eda Mehtap Uc, Rıfat Emin Bora, Hayriye Genc Bilgicli, Mehmet Abdullah Alagöz, Mustafa Zengin, İlhami Gülçin. Synthesis, characterization, and computational study of novel carvacrol-based 2-aminothiol and sulfonic acid derivatives as metabolic enzyme inhibitors. Journal of Molecular Structure 2024, 1303 , 137516.
    9. Eric Lazartigues, Catherine Llorens-Cortes, A.H. Jan Danser. New Approaches Targeting the Renin-Angiotensin System: Inhibition of Brain Aminopeptidase A, ACE2 Ubiquitination, and Angiotensinogen. Canadian Journal of Cardiology 2023, 39 (12) , 1900-1912.
    10. Isel Pascual Alonso, Yarini Arrebola Sánchez, Fabiola Almeida García, Mario Ernesto Valdés Tresanco, Sandra del Valle Peláiz, Daniel Ojeda del Sol, Talía Frómeta Fuentes, Thalía Acén Ravelo, Belinda Sánchez Ramírez. Mammalian aminopeptidase A: biochemical characteristics, physiological roles and physiopathological implications. Pure and Applied Chemistry 2023, 95 (7) , 779-797.
    11. Solène E. Boitard, Mathilde Keck, Robin Deloux, Pierre-Emmanuel Girault-Sotias, Yannick Marc, Nadia De Mota, Delphine Compere, Onnik Agbulut, Fabrice Balavoine, Catherine Llorens-Cortes. QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction. Canadian Journal of Cardiology 2022, 38 (6) , 815-827.
    12. Annamaria Mascolo, Gabriella di Mauro, Donato Cappetta, Antonella De Angelis, Daniele Torella, Konrad Urbanek, Liberato Berrino, Giovanni Francesco Nicoletti, Annalisa Capuano, Francesco Rossi. Current and future therapeutic perspective in chronic heart failure. Pharmacological Research 2022, 175 , 106035.
    13. Jagjit Khosla, Wilbert S. Aronow, William H. Frishman. Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic Hypertension. Cardiology in Review 2022, 30 (1) , 50-55.
    14. Raúl Loera-Valencia, Francesca Eroli, Sara Garcia-Ptacek, Silvia Maioli. Brain Renin–Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer’s Disease. International Journal of Molecular Sciences 2021, 22 (18) , 10139.
    15. Reda Hmazzou, Yannick Marc, Adrien Flahault, Romain Gerbier, Nadia De Mota, Catherine Llorens-Cortes. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension. Clinical Science 2021, 135 (6) , 775-791.
    16. Qiannan Gao, Li Xu, Jun Cai. New drug targets for hypertension: A literature review. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021, 1867 (3) , 166037.
    17. Sara Abdulrahman Alomar, Sarah Ali Alghabban, Hadeel Abdulaziz Alharbi, Mehad Fahad Almoqati, Yazid Alduraibi, Ahmed Abu-Zaid. Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: a review of clinical trials. Avicenna Journal of Medicine 2021, 11 (01) , 1-7.
    18. Nicholas Barlow, Philip E. Thompson. IRAP Inhibitors: M1-Aminopeptidase Family Inspiration. Frontiers in Pharmacology 2020, 11
    19. Félix Vargas, Rosemary Wangesteen, Isabel Rodríguez-Gómez, Joaquín García-Estañ. Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers. International Journal of Molecular Sciences 2020, 21 (16) , 5615.
    20. Yannick Marc, Solène Emmanuelle Boitard, Fabrice Balavoine, Michel Azizi, Catherine Llorens-Cortes. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure. Canadian Journal of Cardiology 2020, 36 (5) , 721-731.
    21. Catherine Llorens-Cortes, Rhian M. Touyz. Evolution of a New Class of Antihypertensive Drugs. Hypertension 2020, 75 (1) , 6-15.
    22. Lauren B. Arendse, A. H. Jan Danser, Marko Poglitsch, Rhian M. Touyz, John C. Burnett, Catherine Llorens-Cortes, Mario R. Ehlers, Edward D. Sturrock, . Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. Pharmacological Reviews 2019, 71 (4) , 539-570.
    23. Michel Azizi, Pierre-Yves Courand, Thierry Denolle, Pascal Delsart, Valentina Zhygalina, Laurence Amar, Pierre Lantelme, Claire Mounier-Vehier, Nadia De Mota, Fabrice Balavoine, Catherine Llorens-Cortes. A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension. Journal of Hypertension 2019, 37 (8) , 1722-1728.
    24. Mathilde Keck, Reda Hmazzou, Catherine Llorens-Cortes. Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions. Current Hypertension Reports 2019, 21 (7)
    25. Mathilde Keck, Hugo De Almeida, Delphine Compère, Nicolas Inguimbert, Adrien Flahault, Fabrice Balavoine, Bernard Roques, Catherine Llorens-Cortes. NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension. Hypertension 2019, 73 (6) , 1300-1307.
    26. Solène Emmanuelle Boitard, Yannick Marc, Mathilde Keck, Nathalie Mougenot, Onnik Agbulut, Fabrice Balavoine, Catherine Llorens-Cortes. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice. Journal of Molecular and Cellular Cardiology 2019, 127 , 215-222.
    27. Yannick Marc, Reda Hmazzou, Fabrice Balavoine, Adrien Flahault, Catherine Llorens-Cortes. Central antihypertensive effects of chronic treatment with RB150. Journal of Hypertension 2018, 36 (3) , 641-650.
    28. Phillip G Kopf, Sang-Kyu Park, Anja Herrnreiter, Christian Krause, Bernard P Roques, William B Campbell. Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell–Mediated Relaxations of Bovine Adrenal Cortical Arteries. Endocrinology 2018, 159 (1) , 238-247.
    29. R. Hmazzou, C. Llorens-Cortes. Inhibiteurs de l’aminopeptidase A comme nouveau traitement potentiel de l’hypertension artérielle. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2017, 2017 (262) , 21-24.
    30. Pierre Couvineau, Hugo de Almeida, Bernard Maigret, Catherine Llorens-Cortes, Xavier Iturrioz, . Involvement of arginine 878 together with Ca2+ in mouse aminopeptidase A substrate specificity for N-terminal acidic amino-acid residues. PLOS ONE 2017, 12 (9) , e0184237.
    31. Patrick Gavin Kehoe, Elliott Hibbs, Laura E. Palmer, J. Scott Miners. Angiotensin-III is Increased in Alzheimer’s Disease in Association with Amyloid-β and Tau Pathology. Journal of Alzheimer's Disease 2017, 58 (1) , 203-214.
    32. Nyssa Drinkwater, Jisook Lee, Wei Yang, Tess R. Malcolm, Sheena McGowan. M1 aminopeptidases as drug targets: broad applications or therapeutic niche?. The FEBS Journal 2017, 284 (10) , 1473-1488.
    33. John W. Wright, Leen H. Kawas, Joseph W. Harding. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology 2015, 125 , 26-46.
    34. Mudumala Veeranarayana Reddy, Gangireddy Chandra Sekhar Reddy, Reddi Mohan Naidu Kalla, Yeon Tae Jeong. Chlorosulfonic acid supported diethylamine ionic liquid catalyzed green synthesis of novel 2-mercaptonaphthalen-1-yl)methyl)-3-hydroxy-5,5-dimethylcyclohex-2-enones under neat conditions. RSC Advances 2015, 5 (44) , 35267-35273.
    35. Robert C. Speth, Eduardo J. Carrera, Catalina Bretón, Andrea Linares, Luz Gonzalez-Reiley, Jamala D. Swindle, Kira L. Santos, Ines Schadock, Michael Bader, Vardan T. Karamyan, . Distribution of Non-AT1, Non-AT2 Binding of 125I-Sarcosine1, Isoleucine8 Angiotensin II in Neurolysin Knockout Mouse Brains. PLoS ONE 2014, 9 (8) , e105762.
    36. Ji Gao, Yannick Marc, Xavier Iturrioz, Vincent Leroux, Fabrice Balavoine, Catherine Llorens-Cortes. A new strategy for treating hypertension by blocking the activity of the brain renin–angiotensin system with aminopeptidase A inhibitors. Clinical Science 2014, 127 (3) , 135-148.
    37. KALISANKAR BERA, DWAYAJA NADKARNI, IRISHI N N NAMBOOTHIRI. Asymmetric synthesis of $\boldsymbol{\gamma}$ -aminophosphonates: The bio-isosteric analogs of $\boldsymbol{\gamma}$ -aminobutyric acid. Journal of Chemical Sciences 2013, 125 (3) , 443-465.
    38. Bing S. Huang, Monir Ahmad, Roselyn A. White, Yannick Marc, Catherine Llorens-Cortes, Frans H.H. Leenen. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction. Cardiovascular Research 2013, 97 (3) , 424-431.
    39. John W. Wright, Joseph W. Harding. The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases. Pflügers Archiv - European Journal of Physiology 2013, 465 (1) , 133-151.
    40. Jiyang O-Wang, Max D. Cooper, Xavier Iturrioz, Catherine Llorens-Cortes. Glutamyl Aminopeptidase. 2013, 410-414.
    41. Guillaume Mercey, Vincent Reboul, Mihaela Gulea, Jocelyne Levillain, Annie‐Claude Gaumont. Synthetic Methodologies for the Preparation of β‐Amino Thiols. European Journal of Organic Chemistry 2012, 2012 (28) , 5423-5434.
    42. Yannick Marc, Ji Gao, Fabrice Balavoine, Annie Michaud, Bernard P. Roques, Catherine Llorens-Cortes. Central Antihypertensive Effects of Orally Active Aminopeptidase A Inhibitors in Spontaneously Hypertensive Rats. Hypertension 2012, 60 (2) , 411-418.
    43. John W. Wright, Shigehiko Mizutani, Joseph W. Harding. Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension. International Journal of Hypertension 2012, 2012 , 1-12.
    44. Yannick Marc, Catherine Llorens-Cortes. The role of the brain renin–angiotensin system in hypertension: Implications for new treatment. Progress in Neurobiology 2011, 95 (2) , 89-103.
    45. John W. Wright, Joseph W. Harding. Brain renin-angiotensin—A new look at an old system. Progress in Neurobiology 2011, 95 (1) , 49-67.
    46. R.B. Nasir Baig, N.Y. Phani Kumar, Jamsad Mannuthodikayil, Srinivasan Chandrasekaran. Synthesis of amino thiols and isocysteines via regioselective ring opening of sulfamidates with tetrathiomolybdate. Tetrahedron 2011, 67 (17) , 3111-3118.
    47. Artur Mucha, Marcin Drag, John P. Dalton, Paweł Kafarski. Metallo-aminopeptidase inhibitors. Biochimie 2010, 92 (11) , 1509-1529.
    48. John W. Wright, Joseph W. Harding. The brain RAS and Alzheimer's disease. Experimental Neurology 2010, 223 (2) , 326-333.
    49. John W. Wright, Joseph W. Harding. The brain angiotensin IV/AT 4 receptor system as a new target for the treatment of Alzheimer's disease. Drug Development Research 2009, 70 (7) , 472-480.
    50. Celia Clarke, Stéphanie Foussat, David J. Fox, Daniel Sejer Pedersen, Stuart Warren. Asymmetric synthesis of trans-disubstituted cyclopropanes using phosphine oxides and phosphine boranes. Org. Biomol. Chem. 2009, 7 (7) , 1323-1328.
    51. Cédric Claperon, Raphael Rozenfeld, Xavier Iturrioz, Nicolas Inguimbert, Mayumi Okada, Bernard Roques, Bernard Maigret, Catherine Llorens-Cortes. Asp218 participates with Asp213 to bind a Ca2+ atom into the S1 subsite of aminopeptidase A: a key element for substrate specificity. Biochemical Journal 2008, 416 (1) , 37-46.
    52. Shigehiko Mizutani, Masakazu Ishii, Akira Hattori, Seiji Nomura, Yasushi Numaguchi, Masafumi Tsujimoto, Hiroshi Kobayshi, Toyoaki Murohara, John W. Wright. New insights into the importance of aminopeptidase A in hypertension. Heart Failure Reviews 2008, 13 (3) , 273-284.
    53. Robert C. Speth, Vardan T. Karamyan. The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain. Heart Failure Reviews 2008, 13 (3) , 299-309.
    54. Nadia De Mota, Xavier Iturrioz, Cedric Claperon, Laurence Bodineau, Celine Fassot, Bernard Pierre Roques, Miklos Palkovits, Catherine Llorens‐Cortes. Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei. Journal of Neurochemistry 2008, 106 (1) , 416-428.
    55. Ranjita J. Kokje, Wendy L. Wilson, Travis E. Brown, Vardan T. Karamyan, John W. Wright, Robert C. Speth. Central Pressor Actions of Aminopeptidase-Resistant Angiotensin II Analogs. Hypertension 2007, 49 (6) , 1328-1335.
    56. Brigitte Bauvois, Daniel Dauzonne. Aminopeptidase-N/CD13 (EC inhibitors: Chemistry, biological evaluations, and therapeutic prospects. Medicinal Research Reviews 2006, 26 (1) , 88-130.
    57. J. W. Wright, J. W. Harding. Angiotensins in Brain Function. 2006, 627-653.
    58. Wendy L. Wilson, Bernard P. Roques, Catherine Llorens-Cortes, Robert C. Speth, Joseph W. Harding, John W. Wright. Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Research 2005, 1060 (1-2) , 108-117.
    59. N. Inguimbert, P. Coric, H. Dhotel, E. Bonnard, C. Llorens‐Cortes, N. De Mota, M.‐C. Fournié‐Zaluski, B.‐P. Roques. Synthesis and in vitro activities of new non‐peptidic APA Inhibitors. The Journal of Peptide Research 2005, 65 (2) , 175-188.
    60. A. Pelegrini-da-Silva, A.R. Martins, W.A. Prado. A new role for the renin—angiotensin system in the rat periaqueductal gray matter: Angiotensin receptor-mediated modulation of nociception. Neuroscience 2005, 132 (2) , 453-463.
    61. Arjan H. G. Siebum, Robert K. F. Tsang, Rob van der Steen, Jan Raap, Johan Lugtenburg. Synthesis of (ϵ‐ 13 C‐,ϵ‐ 15 N)‐Enriched L ‐Lysine − Establishing Schemes for the Preparation of All Possible 13 C and 15 N Isotopomers of L ‐Lysine, L ‐Ornithine, and L ‐Proline. European Journal of Organic Chemistry 2004, 2004 (21) , 4391-4396.
    62. Raphaël Rozenfeld, Laurent Muller, Said El Messari, Catherine Llorens-Cortes. The C-terminal Domain of Aminopeptidase A Is an Intramolecular Chaperone Required for the Correct Folding, Cell Surface Expression, and Activity of This Monozinc Aminopeptidase. Journal of Biological Chemistry 2004, 279 (41) , 43285-43295.
    63. Armand Blommaert, Serge Turcaud, Christine Anne, Bernard P Roques. Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity. Bioorganic & Medicinal Chemistry 2004, 12 (11) , 3055-3062.
    64. Éva Eszter Bagi, Éva Fekete, Dániel Bányai, László Lénárd. Effects of angiotensin II and AIII microinjections into the zona incerta after intra- and extracellular fluid loss. Brain Research 2004, 1002 (1-2) , 110-119.
    65. John W Wright, Joseph W Harding. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Progress in Neurobiology 2004, 72 (4) , 263-293.
    66. Paul Armstrong, Stephanie Feutren, Helena McAlonan, Gavin O’Mahony, Paul J. Stevenson. Synthesis of the putative structures of homopumiliotoxins 235C and 233F. Tetrahedron Letters 2004, 45 (8) , 1627-1630.
    67. Éva Eszter Bagi, Éva Fekete, László Lénárd. Angiotensin II and III microinjections into the zona incerta influence drinking behavior. Brain Research 2003, 977 (2) , 199-208.
    68. John W. Wright, Elizabeth Tamura-Myers, Wendy L. Wilson, Bernard P. Roques, Catherine Llorens-Cortes, Robert C. Speth, Joseph W. Harding. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2003, 284 (3) , R725-R733.
    69. John W Wright, Jennifer R Reichert, Christopher J Davis, Joseph W Harding. Neural plasticity and the brain renin–angiotensin system. Neuroscience & Biobehavioral Reviews 2002, 26 (5) , 529-552.
    70. Jean-Stéphane Poumarat, Pascal Houillier, Claude Rismondo, Bernard Roques, George Lazar, Michel Paillard, Anne Blanchard. The luminal membrane of rat thick limb expresses AT1 receptor and aminopeptidase activities. Kidney International 2002, 62 (2) , 434-445.
    71. Raphaël Rozenfeld, Xavier Iturrioz, Bernard Maigret, Catherine Llorens-Cortes. Contribution of Molecular Modeling and Site-directed Mutagenesis to the Identification of Two Structural Residues, Arg-220 and Asp-227, in Aminopeptidase A. Journal of Biological Chemistry 2002, 277 (32) , 29242-29252.
    72. Sang-Hyeup Lee, Xin Qi, Juyoung Yoon, Kensuke Nakamura, Yoon-Sik Lee. Preparation of β-amino-α-mercapto acids and amides: stereocontrolled syntheses of 2′-sulfur analogues of the taxol C-13 side chain, both syn and anti S-acetyl-N-benzoyl-3-phenylisocysteine. Tetrahedron 2002, 58 (14) , 2777-2787.
    73. John W Wright, Enikö A Kramár, Starla E Meighan, Joseph W Harding. Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system. Peptides 2002, 23 (1) , 221-246.
    74. Annabelle Reaux, Marie Claude Fournie-Zaluski, Catherine Llorens-Cortes. Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends in Endocrinology & Metabolism 2001, 12 (4) , 157-162.
    75. Christelle David-Basei, Marie-Claude Fournié-Zaluski, Bernard P Roques. Aminopeptidase A inhibitors. Expert Opinion on Therapeutic Patents 2001, 11 (3) , 431-444.
    76. Christelle David, Laurent Bischoff, Bernard P Roques, Marie-Claude Fournié-Zaluski. Straightforward and Diastereoselective Synthesis of Tetrafunctionalized Thiol Synthons for the Design of Metallopeptidase Inhibitors. Tetrahedron 2000, 56 (2) , 209-215.
    77. Patrick R. Meffre. Syntheses of optically active 2-amino-4-oxobutyric acid and N,O-protected derivatives. Amino Acids 1999, 16 (3-4) , 251-272.
    78. Annette Hus-Citharel, Jean-Marie Gasc, Sylvie Zini, Jeannine Marchetti, Bernard Roques, Pierre Corvol, Catherine Llorens-Cortes. Aminopeptidase A activity and angiotensin III effects on [Ca2+]i along the rat nephron. Kidney International 1999, 56 (3) , 850-859.
    79. Dominique Chansel, Stanislas Czekalski, Sophie Vandermeersch, Emmanuel Ruffet, Marie-Claude Fournié-Zaluski, Raymond Ardaillou. Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells. American Journal of Physiology-Renal Physiology 1998, 275 (4) , F535-F542.
    80. Christelle David, Laurent Bischoff, Hervé Meudal, Catherine Llorens-Cortes, Bernard Pierre Roques, Marie-Claude Fournié-Zaluski. Characterization and inhibition of aminopeptidase A by α-mercapto-β-amino acyl dipeptides. Letters in Peptide Science 1997, 4 (4-6) , 411-414.
    81. Raymond Ardaillou, Dominique Chansel. Synthesis and effects of active fragments of angiotensin II. Kidney International 1997, 52 (6) , 1458-1468.
    82. S. Zini, M‐C. Fournié‐Zaluski, E. Chauvel, B.P. Roques, P. Corvol, C. Llorens‐Cortes. METABOLIC PATHWAYS AND RESPECTIVE ROLES OF BRAIN ANGIOTENSIN II AND III IN VASOPRESSIN RELEASE. Fundamental & Clinical Pharmacology 1997, 11 (S1)
    83. Gunter Wolf, Karel J.M. Assmann, Rolf A.K. Stahl. Overexpression of aminopeptidase A abolishes the growth promoting effects of angiotensin II in cultured mouse mesangial cells. Kidney International 1997, 52 (5) , 1250-1260.
    84. S Zini, P Masdehors, Z Lenkei, M.-C Fournie-Zaluski, B.P Roques, P Corvol, C Llorens-Cortes. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 1997, 78 (4) , 1187-1193.
    85. G. Pattenden, J. I. G. Cadogan, S. V. Ley. A. 1997, 1-26.
    86. Lijun Song, Sherwin Wilk, Dennis P Healy. Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Research 1997, 744 (1) , 1-6.
    87. Gilles Vazeux, Jiyang Wang, Pierre Corvol, Catherine Llorens-Cortès. Identification of Glutamate Residues Essential for Catalytic Activity and Zinc Coordination in Aminopeptidase A. Journal of Biological Chemistry 1996, 271 (15) , 9069-9074.
    88. Martine Migaud, Christiane Durieux, Jason Viereck, Evelyne Soroca-Lucas, Marie-Claude Fournié-Zaluski, Bernard P. Roques. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides 1996, 17 (4) , 601-607.
    89. John W. Wright, Anita J. Bechtholt, Shelley L. Chambers, Joseph W. Harding. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides 1996, 17 (8) , 1365-1371.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect